These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 25759164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer.
    Tseng JR, Yang LY, Lin YC, Liu CY, Pang ST, Hong JH, Yen TC, Wang LJ.
    Contrast Media Mol Imaging; 2018; 2018():8945130. PubMed ID: 30532664
    [Abstract] [Full Text] [Related]

  • 3. 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.
    Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y.
    Radiology; 2017 Feb; 282(2):429-436. PubMed ID: 27513849
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of 18F-Choline PET/CT and MRI functional parameters in prostate cancer.
    Palard-Novello X, Beuzit L, Gambarota G, Le Jeune F, Garin E, Salaün PY, Devillers A, Querellou S, Bourguet P, Saint-Jalmes H.
    Ann Nucl Med; 2019 Jan; 33(1):47-54. PubMed ID: 30219990
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
    Wetter A, Lipponer C, Nensa F, Heusch P, Rübben H, Altenbernd JC, Schlosser T, Bockisch A, Pöppel T, Lauenstein T, Nagarajah J.
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):79-88. PubMed ID: 24085502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
    Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, Nader M, Gruy B, Janetschek G, Langsteger W.
    Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
    [Abstract] [Full Text] [Related]

  • 11. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L, Koole M, Isebaert S, Joniau S, Deroose CM, Oyen R, Lerut E, Budiharto T, Mottaghy F, Bormans G, Van Poppel H, Haustermans K.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1486-92. PubMed ID: 22284686
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 18F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer.
    Metser U, Berlin A, Halankar J, Murphy G, Jhaveri KS, Ghai S, Tau N.
    AJR Am J Roentgenol; 2018 Mar 01; 210(3):635-640. PubMed ID: 29323548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M, Haim S, Zakavi R, Steinmair M, Waldenberger P, Kunit T, Nader M, Langsteger W, Loidl W.
    J Nucl Med; 2013 Jun 01; 54(6):833-40. PubMed ID: 23559588
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Towards improved diagnosis: radiomics and quantitative biomarkers in 18 F-PSMA-1007 and 18 F-fluorocholine PET/CT for prostate cancer recurrence.
    Panagiotidis E, Andreou S, Paschali A, Angeioplasti K, Vlontzou E, Kalathas T, Pipintakou A, Fothiadaki A, Makridou A, Chatzimarkou M, Papanastasiou E, Datseris I, Chatzipavlidou V.
    Nucl Med Commun; 2024 Sep 01; 45(9):796-803. PubMed ID: 38832429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.